Cutaneous Lupus Erythematosus (CLE)Symptoms, Doctors, Treatments, Advances & More
Learn About Cutaneous Lupus Erythematosus (CLE)
Northwell Health Physician Partners Rheumatology At Great Neck
Richard Furie is a Rheumatologist practicing medicine in Great Neck, New York. Dr. Furie is rated as an Elite provider by MediFind in the treatment of Cutaneous Lupus Erythematosus (CLE). He is also highly rated in 8 other conditions, according to our data. His clinical expertise encompasses Lupus Nephritis, Systemic Lupus Erythematosus (SLE), Cutaneous Lupus Erythematosus (CLE), and Discoid Lupus Erythematosus (DLE). Dr. Furie is board certified in American Board Of Internal Medicine and American Board Of Internal Medicine/Rheumatology.
Johns Hopkins Outpatient Center
Michelle Petri, M.D. is a Professor of Medicine at the Johns Hopkins University School of Medicine. She attended medical school at Harvard University and fulfilled her internal medicine residency at the Massachusetts General Hospital. In addition, she completed two fellowship programs at the University of California, San Francisco in allergy and immunology and rheumatology. Dr. Petri is the Director of the Hopkins Lupus Cohort, a longitudinal study of morbidity and mortality in systemic lupus erythematosus, and Co-Director of the Hopkins Lupus Pregnancy Center. Dr. Petri is rated as an Elite provider by MediFind in the treatment of Cutaneous Lupus Erythematosus (CLE). She is also highly rated in 10 other conditions, according to our data. Her clinical expertise encompasses Lupus Nephritis, Systemic Lupus Erythematosus (SLE), Cutaneous Lupus Erythematosus (CLE), Tenotomy, and Osteotomy. Dr. Petri is board certified in American Board Of Internal Medicine and American Board Of Allergy And Immunology.
Montefiore At AECOM
Chaim Putterman, MD - Summary of Research Program and Goals. Dr. Putterman is rated as an Elite provider by MediFind in the treatment of Cutaneous Lupus Erythematosus (CLE). He is also highly rated in 7 other conditions, according to our data. His clinical expertise encompasses Lupus Nephritis, Systemic Lupus Erythematosus (SLE), Cutaneous Lupus Erythematosus (CLE), and Vasculitis.
Summary: The goal of this clinical trial is to learn if VENT-03 works to treat patients with cutaneous lupus erythematosus (CLE) who may or may not have systemic lupus erythematosus (SLE). Another goal is to learn about the safety of VENT-03 and how it is processed by the body. The main questions it aims to answer are: * Does VENT-03 affect the activity and severity of CLE? * What side effects do participa...
Summary: The purpose of this global, multicenter, Phase 3 study is to evaluate the efficacy and safety of enpatoran over 24 weeks in participants with active cutaneous manifestations of lupus erythematosus with or without systemic disease. Study details include: Study Duration: Up to 35 weeks. Treatment Duration: 24 weeks. Visit Frequency: every 4 weeks, with the exception of the Week 2 televisit. Study In...